Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
YK Bioventures Opportunities GP I, LLC Insider Profile
4 Followers
YK Bioventures Opportunities GP I, LLC, Ten Percent Owner at CERo Therapeutics Holdings, holds 13.01M shares in CERo Therapeutics Holdings (Ticker: CERO). Most recently, YK Bioventures Opportunities GP I, LLC Sold $5,957,250 shares of CERo Therapeutics Holdings on Dec 13, 2024 for an estimated value of 400.46K.
YK Bioventures Opportunities GP I, LLC has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of YK Bioventures Opportunities GP I, LLC's holdings
Insider Roles
Ten Percent Owner
Roles that YK Bioventures Opportunities GP I, LLC holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by YK Bioventures Opportunities GP I, LLC
YK Bioventures Opportunities GP I, LLC's Trading History
List of latest transactions for each holding click on a transaction to see YK Bioventures Opportunities GP I, LLC's performance on stock
You May Also Like
YK Bioventures Opportunities GP I, LLC insider profile FAQ
What is the percentage of profitable transactions made by YK Bioventures Opportunities GP I, LLC?
The percentage of profitable transactions made by YK Bioventures Opportunities GP I, LLC is ―.
What is the average return per transaction made by YK Bioventures Opportunities GP I, LLC?
The average return per transaction made by YK Bioventures Opportunities GP I, LLC is ―.
What stocks does YK Bioventures Opportunities GP I, LLC hold?
YK Bioventures Opportunities GP I, LLC holds: CERO stocks.
What was YK Bioventures Opportunities GP I, LLC’s latest transaction?
YK Bioventures Opportunities GP I, LLC latest transaction was an Informative Sell of $400.46K.
What was YK Bioventures Opportunities GP I, LLC's most profitable transaction?
YK Bioventures Opportunities GP I, LLC’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is YK Bioventures Opportunities GP I, LLC's role in CERo Therapeutics Holdings?
YK Bioventures Opportunities GP I, LLC's role in CERo Therapeutics Holdings is Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.